Literature DB >> 2959614

A suppressor B lymphocyte inhibiting IL-2 consumption in spleen cell cultures from Mycobacterium bovis BCG-infected mice.

R Turcotte1.   

Abstract

In concanavalin A (Con A)-activated spleen cell (SC) cultures from normal C57BL/6 mice, the production of IL-2 peaked at 18-20 hr after initiation of cultures and declined rapidly during the next 24 hr, the decline of IL-2 activity being due, at least in part, to its utilization by the Con A-induced IL-2 receptor cells. In Con A-activated SC from BCG-infected mice, significant levels of IL-2 activity persisted in the 48-hr and 72-hr culture supernatants, a situation which seemed to be related to the depressed capacity of infected splenocytes to acquire IL-2 receptors. In cell mixing experiments, SC from infected mice actively depressed the utilization of IL-2 by Con A-activated normal SC, thus indicating that suppressor cells can down-regulate IL-2 responsiveness. These suppressor cells may belong to the B-cell lineage since they possessed the Thy-1-, sIg+ and FcR+ phenotype.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2959614      PMCID: PMC1454133     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  34 in total

1.  Interleukin 2 receptors are released by cells in vitro and in vivo. I. Detection of soluble IL 2 receptors in cell culture supernatants and in the serum of mice by an immunoradiometric assay.

Authors:  H Osawa; O Josimovic-Alasevic; T Diamantstein
Journal:  Eur J Immunol       Date:  1986-04       Impact factor: 5.532

2.  Mechanisms underlying the depressed production of interleukin-2 in spleen and lymph node cell cultures of mice infected with Mycobacterium bovis BCG.

Authors:  R Turcotte; D Legault
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

3.  Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2.

Authors:  N Mohagheghpour; R H Gelber; J W Larrick; D T Sasaki; P J Brennan; E G Engleman
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

4.  Interleukin 2 regulates expression of its receptor and synthesis of gamma interferon by human T lymphocytes.

Authors:  G H Reem; N H Yeh
Journal:  Science       Date:  1984-07-27       Impact factor: 47.728

5.  In vivo and in vitro administration of interleukin 2-containing preparation reverses T-cell unresponsiveness in Mycobacterium bovis BCG-infected mice.

Authors:  V Colizzi
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

6.  Kinetics of IL-2 and interferon-gamma production, expression of IL-2 receptors, and cell proliferation in human mononuclear cells exposed to staphylococcal enterotoxin A.

Authors:  R Carlsson; H O Sjögren
Journal:  Cell Immunol       Date:  1985-11       Impact factor: 4.868

7.  Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.

Authors:  L A Rubin; C C Kurman; M E Fritz; W E Biddison; B Boutin; R Yarchoan; D L Nelson
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

8.  Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis.

Authors:  Z Toossi; M E Kleinhenz; J J Ellner
Journal:  J Exp Med       Date:  1986-05-01       Impact factor: 14.307

9.  Activated B cells express receptors for, and proliferate in response to, pure interleukin 2.

Authors:  R H Zubler; J W Lowenthal; F Erard; N Hashimoto; R Devos; H R MacDonald
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

10.  Interleukin 2 regulates the expression of Tac antigen on peripheral blood T lymphocytes.

Authors:  K Welte; M Andreeff; E Platzer; K Holloway; B Y Rubin; M A Moore; R Mertelsmann
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

View more
  3 in total

1.  Dietary protein deficiency and Mycobacterium bovis BCG affect interleukin-2 activity in experimental pulmonary tuberculosis.

Authors:  D N McMurray; C L Mintzer; R A Bartow; R L Parr
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

2.  CD4-mediated and CD8-mediated cytotoxic and proliferative immune responses to Toxoplasma gondii in seropositive humans.

Authors:  M B Purner; R L Berens; P B Nash; A van Linden; E Ross; C Kruse; E C Krug; T J Curiel
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

3.  Bacillus Calmette-Guérin (BCG) vaccine generates immunoregulatory cells in the cervical lymph nodes in guinea pigs injected intra dermally.

Authors:  Souzan Vergkizi; Ioannis Nikolakakis
Journal:  Vaccine       Date:  2020-10-16       Impact factor: 4.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.